期刊文献+

基于MR成像获得新辅助治疗后乳腺肿瘤退缩模式与病理反应的相关性 被引量:1

The correlation between breast tumor regression pattern and pathological response after neoadjuvant therapy based on MR imaging
下载PDF
导出
摘要 目的 探讨新辅助治疗(NAT)后基于MR成像获得乳腺肿瘤退缩模式与病理反应的相关性.方法 收集2019年12月至2020年12月NAT后手术前59例局部进展期乳腺癌病灶MR图像退缩模式以及术后病理标本资料,分析两者间的相关性.结果 59例病灶中,向心性收缩38例(64.41%),其中病理缓解31例(81.58%),病理无缓解7例(18.42%);非向心性收缩21例(35.59%),其中病理缓解11例(52.38%),病理无缓解10例(47.62%).乳腺癌肿瘤退缩模式与NAT后病理反应差异有统计学意义(P<0.05).结论 乳腺癌肿瘤退缩模式与NAT后病理反应具有相关性,向心性收缩更多出现病理缓解,非向心性收缩多出现病理无缓解. Objective To investigate the correlation between MR-based patterns of tumor regression and pathological response after neoadjuvant therapy(NAT).Methods The MR image regression patterns and postoperative pathological specimen data of 59 locally advanced breast cancer lesions before surgery were collected from December 2019 to December 2020,and analyze their correlation.Results There were 38 cases(64.41%)of concentric contraction after NAT in 59 cases,including 31 cases(81.58%)of pathological response and 7 cases of non-pathological response(18.42%).Besides,there were 21 cases(35.59%)of non-concentric contraction,which included 11 cases(52.38%)of pathological response and 10 cases of non-pathological response(47.62%).There was significant difference between the pattern of tumor regression after NAT and pathological response(P<0.05).Conclusion There is significant correlation between the pattern of tumor regression after NAT and pathological response.the tumors with concentric shrinkage on MRI present more pathological response and the tumors with non-concentric shrinkage present more non-pathological response.
作者 南帅明 邓雪英 Nan Shuaioming
出处 《浙江临床医学》 2022年第5期663-665,共3页 Zhejiang Clinical Medical Journal
基金 浙江省卫生健康科技计划资助项目(2021KY091)。
关键词 乳腺癌 分子亚型 磁共振成像 肿瘤退缩模式 新辅助治疗 Breast cancer Molecular subtypes Magnetic resonance imaging Tumor regression Neoadjuvant therapy
  • 相关文献

参考文献4

二级参考文献45

  • 1Fan L, Strasser-Weippl K, Li JJ, et al. breast cancer in china. [J]. Lancet Oneol, 2014, 15(7) :279-289.
  • 2Mamounas EP. Impact of neoadjuvant chemotherapy on locore gional surgical treatment of breast cancer[J]. Ann Surg Oneo[, 2015,22(5) : 1425-1433.
  • 3Garg AK, Buchholz TA. Influence of neoadjuvant chemotherapy on radiotherapy for breast eancer[J]. Ann Surg Oncol,2015,22 (5) : 1434-1440.
  • 4Hayes DF, Schott AF. Neoadjuvant chemotherapy: what are the benefits for the patient and for the investigator? [J]. J Natl Cancer Inst Monogr,2015,2015(51) :36-39.
  • 5Golshan M, Cirrincione CT, Sikov WM, et al. Impact of neoad juvant chemotherapy in stage Ⅱ- Ⅲ triple negative breast cane er on eligibility for breast-conserving surgery and breast conser- vation rates: surgical results from CALGB 40603 (Alliance)EJ]. Ann Surg,2015,262(3) :434 439.
  • 6Untch M, Harbeck N, Huober J, et al. Primary therapy of pa- tients with early breast cancer: evidence, controversies, consen sus: opinions of german specialists to the 14th St. gallen inter national breast cancer conference 2015 (Vienna 2015)[J]. Ge hurtshilfe Frauenheilkd, 2015,75 ( 6 ) : 556-565.
  • 7Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast conser- vation after neoadjuvant chemotherapy [J]. Cancer, 2005, 103 (4):689 695.
  • 8Akay CL, Meric Bernstam F, Hunt KK, et al. Evaluation of the MD anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadiuvant chemotherapy[J]. Ann Surg Oncol,2012,19(3):901 907.
  • 9Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. J Clin Oncol, 2010,28(16) :2784-2795.
  • 10Cancer Genome Atlas Network. Comprehensive molecular por- traits of human breast tumours[J]. Nature, 2012,490(7418): 61-70.

共引文献1205

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部